METYRAPONE for Adrenocortical carcinoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where METYRAPONE was used for Adrenocortical carcinoma.
Most Reported Side Effects for METYRAPONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 277 | 50.3% | 9 | 20 |
| Nausea | 53 | 9.6% | 3 | 13 |
| Drug ineffective | 39 | 7.1% | 4 | 18 |
| Pneumocystis jirovecii pneumonia | 31 | 5.6% | 8 | 25 |
| Fatigue | 30 | 5.4% | 5 | 3 |
| Vomiting | 27 | 4.9% | 2 | 10 |
| Dizziness | 26 | 4.7% | 0 | 2 |
| Adrenal insufficiency | 23 | 4.2% | 2 | 11 |
| Anaemia | 23 | 4.2% | 2 | 7 |
| Exposure during pregnancy | 22 | 4.0% | 0 | 5 |
| Asthenia | 20 | 3.6% | 2 | 3 |
| Diarrhoea | 20 | 3.6% | 0 | 6 |
| Premature baby | 19 | 3.5% | 0 | 7 |
| Maternal exposure during pregnancy | 18 | 3.3% | 1 | 5 |
| Foetal exposure during pregnancy | 16 | 2.9% | 0 | 5 |
Other Indications for METYRAPONE
Cushing's syndrome (177)
Pituitary-dependent cushing's syndrome (88)
Product used for unknown indication (37)
Adrenal gland cancer (33)
Ectopic acth syndrome (32)
Hyperadrenocorticism (27)
Cortisol increased (11)
Diagnostic procedure (8)
Exposure during pregnancy (8)
Hypercorticoidism (6)
Other Drugs Used for Adrenocortical carcinoma
MITOTANE (461)
ETOPOSIDE (263)
CISPLATIN (219)
DOXORUBICIN (219)
PEMBROLIZUMAB (56)
CARBOPLATIN (48)
CABOZANTINIB S-MALATE (27)
NIVOLUMAB (27)
CAPECITABINE (22)
GEMCITABINE (22)